Allurion Technologies, Inc. Operating Lease Cost
Allurion Technologies, Inc. (ALUR) reported Operating Lease Cost of $157.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-05-15
- Allurion Technologies, Inc. operating lease, cost for the quarter ending 2026-03-31 was $157.00K, a 39.15% decline year-over-year.
- Allurion Technologies, Inc. operating lease, cost for the quarter ending 2025-12-31 was $153.00K, a 40.47% decline year-over-year.
- Allurion Technologies, Inc. operating lease, cost for the quarter ending 2025-09-30 was $190.00K, a 26.64% decline year-over-year.
- Allurion Technologies, Inc. operating lease, cost for the quarter ending 2025-06-30 was $224.00K, a 12.84% decline year-over-year.
- Allurion Technologies, Inc. operating lease, cost for fiscal 2025 was $825.00K, a 21.50% decline from fiscal 2024.
- Allurion Technologies, Inc. operating lease, cost for fiscal 2024 was $1.05M, a 6.41% decline from fiscal 2023.
- Allurion Technologies, Inc. operating lease, cost for fiscal 2023 was $1.12M, a 22.33% increase from fiscal 2022.
- Allurion Technologies, Inc. operating lease, cost for fiscal 2022 was $918.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-03-31 | $157.00K 10-Q · filed 2026-05-15 | $310.00K derived: sum of 2 quarters · filed 2026-05-15 | $500.00K derived: sum of 3 quarters · filed 2026-05-15 | $724.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $343.00K derived: sum of 2 quarters · filed 2026-03-30 | $567.00K derived: sum of 3 quarters · filed 2026-03-30 | $825.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $190.00K 10-Q · filed 2025-11-17 | $414.00K derived: sum of 2 quarters · filed 2025-11-17 | $672.00K 10-Q · filed 2025-11-17 | $929.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $224.00K 10-Q · filed 2025-08-19 | $482.00K 10-Q · filed 2025-08-19 | $739.00K derived: sum of 3 quarters · filed 2026-05-15 | $998.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $258.00K 10-Q · filed 2026-05-15 | $515.00K derived: sum of 2 quarters · filed 2026-05-15 | $774.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.03M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $516.00K derived: sum of 2 quarters · filed 2026-03-30 | $773.00K derived: sum of 3 quarters · filed 2026-03-30 | $1.05M 10-K · filed 2026-03-30 |
| 2024-09-30 | $259.00K 10-Q · filed 2025-11-17 | $516.00K derived: sum of 2 quarters · filed 2025-11-17 | $794.00K 10-Q · filed 2025-11-17 | $1.08M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $257.00K 10-Q/A · filed 2025-08-28 | $535.00K 10-Q/A · filed 2025-08-28 | $824.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.11M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $278.00K 10-Q/A · filed 2025-08-28 | $567.00K derived: sum of 2 quarters · filed 2025-08-28 | $852.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.13M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $289.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $574.00K derived: sum of 2 quarters · filed 2025-08-28 | $849.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.12M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $285.00K 10-Q/A · filed 2025-08-28 | $560.00K derived: sum of 2 quarters · filed 2025-08-28 | $834.00K 10-Q/A · filed 2025-08-28 | $1.11M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $275.00K 10-Q/A · filed 2025-08-28 | $549.00K 10-Q/A · filed 2025-08-28 | $823.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.07M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $274.00K 10-Q/A · filed 2025-08-28 | $548.00K derived: sum of 2 quarters · filed 2025-08-28 | $793.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.00M derived: sum of 4 quarters · filed 2025-08-28 |
| 2022-12-31 | $274.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $519.00K derived: sum of 2 quarters · filed 2025-08-28 | $726.00K derived: sum of 3 quarters · filed 2025-08-28 | $918.00K 10-K/A · filed 2025-08-28 |
| 2022-09-30 | $245.00K 10-Q · filed 2023-11-14 | $452.00K derived: sum of 2 quarters · filed 2023-11-14 | $644.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $207.00K 10-Q · filed 2023-10-20 | $399.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |